11/30
2021

Treatment of Moderate to Severe Ulcerative Colitis with Ozanimod

11:00 am - 12:00 pm
Off Campus
Bryan Sherwood, PharmD
Click link to register

Treatment of Moderate to Severe Ulcerative Colitis with Ozanimod

Schedule:

November 30, 2021, 11am to 12 noon, Dartmouth Hitchcock Medical Center, Lebanon, NH

Audience:

Accredited for Pharmacists

Other interested health care professionals welcome

Credits:

1 Contact Hour knowledge based

0.1CEU will be awarded under the provider

0837-9999-21-231-L01-P                                 

Presenter:

Bryan Sherwood, PharmD, PGY1 Pharmacy Resident, Dartmouth-Hitchcock

Registration:

Free to all attendees

Learning Objectives:

After attending this program, participants will be able to:

  1. Recognize dosing and administration recommendations for ozanimod
  2. Identify necessary safety considerations for ozanimod use
  3. Distinguish between patient populations that may benefit from treatment with ozanimod

Requirements for Receiving CE Credit:

  • Successful completion of post-presentation questions
  • Participation at live program
  • Complete program evaluation form